Long-term analysis of QOL in patients with prostate cancer treated with various hormone therapy

Long-term analysis of QOL in patients with prostate cancer treated with various hormone therapy - Hormone therapy and QOL in prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016371

Enrollment

300

Registered

2015-04-01

Start date

2015-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) male age >20 yo =20yo 2) histologially proven prostate cancer 3) patients supposed to be treated with hormone therapy or those treated with hormone therapy 4)both hormone sensitive and castration-resistant state 5) obtained written informed consent

Exclusion criteria

Exclusion criteria: 1)disablity of QOL assessment by patients or family members 2) other conditions in which physicians considers

Design outcomes

Primary

Measure	Time frame
Comparison of QOL score trend in intra-treatment and inter-treatment.	—

Secondary

Measure	Time frame
Changes of bone mineral density, bone metabolic marker, fat mass, lean mass and hormone levels.	—

Countries

Japan

Contacts

Public ContactKazuhiro Suzuki

Gunma University Graduate School of Medicine Department of Urology

kazu@gunma-u.ac.jp027-220-8300

Outcome results